<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00825006</url>
  </required_header>
  <id_info>
    <org_study_id>SHEBA-08-5076-MG-CTIL</org_study_id>
    <nct_id>NCT00825006</nct_id>
  </id_info>
  <brief_title>The Effects of Anodal Stimulation on Echocardiographic Outcome in Patients With Cardiac Resynchronization Therapy</brief_title>
  <official_title>The Effects of Anodal Stimulation on Left Ventricular Desynchrony and Hemodynamics in Patients With a Biventricular Pacemaker</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sheba Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sheba Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To investigate the hemodynamic, inter and intraventricular desynchrony effects of anodal
      stimulation and triple site pacing compared with the usual dual site pacing by
      echocardiography and Tissue Doppler Imaging.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Thirty patients who underwent CRT and had evidence of anodal stimulation will be included in
      the study. All patients undergo a conventional echocardiography after 10 minutes of
      continuous triple site pacing and after 10 minutes of continuous dual site pacing (Customary
      biventricular pacing).Echocardiography studies will be performed to measure dP/dT using
      continuous flow Doppler velocity profiles of mitral regurgitation, LV volumes and Left
      ventricular ejection fraction. Left intraventricular desynchrony is assessed by using TDI.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2009</start_date>
  <completion_date type="Anticipated">December 2009</completion_date>
  <primary_completion_date type="Anticipated">July 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Myocardial Performance Index, dP/dT</measure>
    <time_frame>After 10 minutes of triple site pacing and 10 minutes of dual sute pacing</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Inter and intraventricular dyssynchrony parameters, LV volumes, LVEF</measure>
    <time_frame>After 10 minutes of triple site pacing and 10 minutes of dual site pacing</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Dual site pacing (LV tip electrode and RV tip electrode)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Triple site pacing</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Triple site pacing(LV tip electrode,RV tip electrode and RV ring electrode)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Triple site pacing mode</intervention_name>
    <description>The experimental &quot;Triple site pacing mode&quot; includes pacing with Cardiac resynchronization therapy device using two leads; one in the right ventricle (RV) and one in the left ventricle (LV) but stimulates three sites: LV tip, RV tip and RV ring (instead of the usual two sites: LV tip and RV ring.
Patients with evidence of improved LV dyssinchrony parameters during the triple pacing mode (anodal stimulation) will be programmed to anodal stimulation for 3 months.</description>
    <arm_group_label>Triple site pacing</arm_group_label>
    <other_name>anodal stimulation, triple site pacing</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with biventricular pacemakers who met currently accepted indications for CRT,
             including dilated cardiomyopathy with LV ejection fraction &lt; 35% (ischemic and
             nonischemic etiologies) with New York Heart Association class III to IV congestive
             heart failure and QRS duration &gt; 120 ms.

        Exclusion Criteria:

          -  Patients with first generation CRT device

          -  Integrated bipolar defibrillator device

          -  Atrial fibrillation during the screening phase

          -  Patients who cannot tolerate triple site pacing for several minutes (i.e diaphragmatic
             pacing)

          -  Patients with epicardial LV leads

          -  Patients with LV leads located out of the lateral or posterolateral areas
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Glikson, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Heart Institute, Sheba Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Michael Glikson, MD</last_name>
    <phone>+97235302604</phone>
    <email>mglikson@tau.ac.il</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Alon Barsheshet, MD</last_name>
    <phone>+97235302604</phone>
    <email>alonyaell@bezeqint.net</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Heart Institute, Sheba Medical Center</name>
      <address>
        <city>Tel Hashomer</city>
        <zip>52621</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alon Barsheshet, MD</last_name>
      <phone>+97235302604</phone>
      <email>alonyaell@bezeqint.net</email>
    </contact>
    <investigator>
      <last_name>Michael Glikson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>January 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 9, 2008</study_first_submitted>
  <study_first_submitted_qc>January 16, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 19, 2009</study_first_posted>
  <last_update_submitted>January 16, 2009</last_update_submitted>
  <last_update_submitted_qc>January 16, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 19, 2009</last_update_posted>
  <responsible_party>
    <name_title>Dr Alon Barsheshet</name_title>
    <organization>Sheba Medical Center, Heart Institute</organization>
  </responsible_party>
  <keyword>Cardiac resynchronization therapy</keyword>
  <keyword>Anodal stimulation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

